PRESS RELEASE

Q4 2020 — Press release (Form 8-K)

Q4 2020PDF · 4 pages155 KB
1/20/2021 unh-20210120
https://www.sec.gov/Archives/edgar/data/731766/000073176621000002/unh-20210120.htm 1/4
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 20, 2021
—————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
Delaware 	1-10864 	41-1321939
(State or other
jurisdiction of
incorporation) 	(Commission File Number) (I.R.S. Employer
Identification No.)
UnitedHealth Group Center, 9900 Bren Road East, 	Minnetonka, Minnesota 55343
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code: (952) 936-1300
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $.01 par value 	UNH 	New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

-- 1 of 4 --

1/20/2021 unh-20210120
https://www.sec.gov/Archives/edgar/data/731766/000073176621000002/unh-20210120.htm 2/4

-- 2 of 4 --

1/20/2021 unh-20210120
https://www.sec.gov/Archives/edgar/data/731766/000073176621000002/unh-20210120.htm 3/4
Item 2.02. Results of Operations and Financial Condition.
On January 20, 2021, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full
year 2020 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor
shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of
1934, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit 	Description
99.1 	Press Release dated January 20, 2021
104 	Cover Page Interactive Data File (formatted as Inline XBRL).

-- 3 of 4 --

1/20/2021 unh-20210120
https://www.sec.gov/Archives/edgar/data/731766/000073176621000002/unh-20210120.htm 4/4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: January 20, 2021
UNITEDHEALTH GROUP INCORPORATED
By: 	/s/ Dannette L. Smith
Dannette L. Smith
Secretary to the Board of Directors

-- 4 of 4 --